drugset / Trial / NCT03312257

Bifocal & Atropine in Myopia (BAM) Study

NCT03312257

Completed 49 enrolled Jenny Jones
NaSingle-groupOpen-labelTreatment

Summary

This study will test whether the combined treatment of 0.01% atropine and soft bifocal contact lens wear produces slower myopia progression and axial elongation compared to soft bifocal contact lenses alone in children ages 7 to 11 years old.

Timeline

Start
2016-07
Primary completion
2020-06
Completion
2020-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Atropine Other / unclassified 0.01 % Other

Indications